PaÆì½¢Ìü¹ÙÍø

×ß½øPaÆì½¢Ìü¹ÙÍø

PaÆì½¢Ìü¹ÙÍø £¬£¬£¬£¬£¬£¬ £¬£¬ÊÇÒ»¼ÒÒÔ¶ùͯҩΪÖ÷ÒµµÄÉÏÊй«Ë¾¡£¡£¡£¡£¡£¡£¹«Ë¾Æð¾¢¼ùÐС°¶ùͯ´ó¿µ½¡Õ½ÂÔ¡±ºÍ¡°¾«Æ·Õ½ÂÔ¡± £¬£¬£¬£¬£¬£¬ £¬£¬ÖÂÁ¦ÓÚ´òÔìÖйú¶ùͯ´ó¿µ½¡¹¤ÒµµÄÁì¾üÆ·ÅÆ¡£¡£¡£¡£¡£¡£

Ͷ×ÊÕß¹ØÏµ

PaÆì½¢Ìü¹ÙÍøÒ©ÒµÊ¼ÖÕ¹Ø×¢Í¶×ÊÕßÈ¨Òæ £¬£¬£¬£¬£¬£¬ £¬£¬Ò»Ö±ÍêÉÆ¹«Ë¾ÖÎÀí £¬£¬£¬£¬£¬£¬ £¬£¬ÌáÉýЧÀÍˮƽ¡£¡£¡£¡£¡£¡£¹«Ë¾ÌṩÁ˶àÖÖÏàͬ;¾¶Ç徲̨ £¬£¬£¬£¬£¬£¬ £¬£¬Ï£ÍûʵÏÖÓëͶ×ÊÕßµÄÁ¼ÐÔ»¥¶¯¡£¡£¡£¡£¡£¡£

PaÆì½¢Ìü¹ÙÍø×ÊѶ

PaÆì½¢Ìü¹ÙÍøÒ©ÒµÆð¾¢¼ùÐС°¶ùͯ´ó¿µ½¡Õ½ÂÔ¡±ºÍ¡°¾«Æ·Õ½ÂÔ¡± £¬£¬£¬£¬£¬£¬ £¬£¬ÖÂÁ¦ÓÚ´òÔìÖйú¶ùͯ´ó¿µ½¡¹¤ÒµµÄÁì¾üÆ·ÅÆ¡£¡£¡£¡£¡£¡£

Éú²úÓëÑз¢

PaÆì½¢Ìü¹ÙÍøÒ©ÒµÔÚº£ÄÏ¡¢±±¾©¡¢ºÓ±±¡¢ÁÉÄþ¡¢¹ã¶«µÈÊ¡ÊÐÓµÓÐÎå´ó¸ß¶È×Ô¶¯»¯¡¢ÖÇÄÜ»¯µÄÉú²ú»ùµØ £¬£¬£¬£¬£¬£¬ £¬£¬²¢ÒÑÔڹ㶫ÖÐɽ½¨ÉèÁËÇкÏÅ·Ã˱ê×¼µÄÐÂÉú²ú»ùµØ¡£¡£¡£¡£¡£¡£¹«Ë¾ÓµÓÐÏȽøµÄÑз¢×°±¸ºÍÓÅÒìµÄÑз¢²½¶Ó £¬£¬£¬£¬£¬£¬ £¬£¬ÀÛ¼ÆÍ¶ÈëÑз¢×ʽðÊýÒÚÔª¡£¡£¡£¡£¡£¡£

Êг¡ÓªÏú

PaÆì½¢Ìü¹ÙÍøÒ©ÒµÔÚº£ÄÚÓµÓнüǧ¸öÊðÀíÉÌ £¬£¬£¬£¬£¬£¬ £¬£¬Áè¼Ý4Íò¸öÏúÊÛÖÕ¶Ë £¬£¬£¬£¬£¬£¬ £¬£¬²¢ÓµÓÐÒ»Ö§¸»ÓÐרҵ¾«Éñ¡¢ÊµÕ½ÂÄÀú¸»ºñµÄÓªÏúÍÅ¶Ó £¬£¬£¬£¬£¬£¬ £¬£¬ÓªÏúÍøÂçÁýÕÖÌìÏ¡£¡£¡£¡£¡£¡£

²úÆ·×¨Çø

PaÆì½¢Ìü¹ÙÍøÒ©ÒµÉî¸û¶ùͯÓÃÒ©Êг¡¶àÄê £¬£¬£¬£¬£¬£¬ £¬£¬ÐγÉÁËÍêÉÆµÄ²úÆ·ÃûÌà £¬£¬£¬£¬£¬£¬ £¬£¬ÓµÓÐÒÔ¡°PaÆì½¢Ìü¹ÙÍø¡±ÎªÖ÷Æ·ÅÆµÄ¶ùͯҩƷ¼¯Èº £¬£¬£¬£¬£¬£¬ £¬£¬ÍƳöÁËÒÔ¡°ÈðÖ¥Ç塱¡¢¡°PaÆì½¢Ìü¹ÙÍøËÉ¡±¡¢¡°PaÆì½¢Ìü¹ÙÍøÌ©¡±¡¢¡°½ðÁ¢Ë¬¡±µÈΪ´ú±íµÄ¶À¾ßPaÆì½¢Ìü¹ÙÍøÌØÉ«µÄÃ÷ÐDzúÆ·¡£¡£¡£¡£¡£¡£

Éç»áÔðÈÎ

2011Äê £¬£¬£¬£¬£¬£¬ £¬£¬PaÆì½¢Ìü¹ÙÍøÐ¯ÊÖÖйú¶ùͯÉÙÄê»ù½ð»áÅäºÏ½¨Éè¡°PaÆì½¢Ìü¹ÙÍøºìÃæÅÓ»ù½ð¡± £¬£¬£¬£¬£¬£¬ £¬£¬Í¨¹ýºìÃæÅÓͼÊé¹Ý¾è½¨¡¢¶ùͯ¿µ½¡¹Ø°®¡¢°®Ðļҷá¢Îï×ʾèÔùµÈ¶àÖÖÐÎʽµÄ¹«ÒæÐж¯ £¬£¬£¬£¬£¬£¬ £¬£¬»Ý¼°ÍòÍò¶ùͯ¡£¡£¡£¡£¡£¡£

ÊÂÇéÔÚPaÆì½¢Ìü¹ÙÍø

PaÆì½¢Ìü¹ÙÍøÒ©ÒµÈ˲ÅÉú³¤ÒÔ¡°Ñ§Ï°¡¢ÌáÉý¡¢Á¢Òì¡¢Éú³¤¡±ÎªÖ¸µ¼ £¬£¬£¬£¬£¬£¬ £¬£¬×ñÕÕ¡°ÆóÒµÒÔÈËΪ±¾¡¢È˲ÅÉú³¤ÒÔÓÃΪ±¾¡±µÄ¿ÆÑ§ÖÎÀíÀíÄî £¬£¬£¬£¬£¬£¬ £¬£¬ÎªÔ±¹¤ºÏÀíÉè¼ÆÖ°Î»Éú³¤ÐòÁÐ £¬£¬£¬£¬£¬£¬ £¬£¬´î½¨Á÷ͨµÄÔ±¹¤Ö°ÒµÉú³¤Í¨µÀ¡£¡£¡£¡£¡£¡£

¿Í»§Ð§ÀÍ

PaÆì½¢Ìü¹ÙÍø½«±ü³Ö¡°Õæ³Ï¡¢¹Ø°®¡¢Á¢Ò족µÄÆóÒµ¾«Éñ £¬£¬£¬£¬£¬£¬ £¬£¬ÒÔרע¶ùͯ¿µ½¡Îª¼ºÈÎ £¬£¬£¬£¬£¬£¬ £¬£¬ÖÂÁ¦ÓÚÇå¾²¡¢ÓÐÓõĶùͯҩÎïÑз¢ £¬£¬£¬£¬£¬£¬ £¬£¬×öÏȽø¿Æ¼¼Ó¦ÓÃÓÚ¶ùͯ¿µ½¡²úÆ·ÓëЧÀÍÁìÓòµÄÏÈÐÐÕß £¬£¬£¬£¬£¬£¬ £¬£¬×ö¶ùͯ¿µ½¡ÉúÑÄ¡¢¿µ½¡Éú³¤µÄÍÆ¶¯ÕߺÍÊØ»¤Éñ¡£¡£¡£¡£¡£¡£

ÄúµÄλÖÃÊÇ£ºÊ×Ò³>PaÆì½¢Ìü¹ÙÍø×ÊѶ>PaÆì½¢Ìü¹ÙÍø¶¯Ì¬
PaÆì½¢Ìü¹ÙÍø¶¯Ì¬Honz news

PaÆì½¢Ìü¹ÙÍøÒ©ÒµSCF PD£¨³¬ÁÙ½çÁ÷ÌåÁ£×ÓÉè¼Æ£©ÊÖÒÕÁ¢ÒìÑо¿È¡µÃÏÔ×ÅÏ£Íû £¬£¬£¬£¬£¬£¬ £¬£¬ ÁÁÏàFormula IX¹ú¼ÊѧÊõ¾Û»á»ñר¼ÒÈÏ¿É



¿ËÈÕ £¬£¬£¬£¬£¬£¬ £¬£¬Formula IX¹ú¼ÊѧÊõ¾Û»áÔÚ±±¾©ÓÑÒê±ö¹ÝÔ²ÂúÕÙ¿ª¡£¡£¡£¡£¡£¡£±¾´Î¾Û»áÓÉÖйú¿ÅÁ£Ñ§»áºÍÖйú»¯¹¤Ñ§»áµÈµ¥Î»ÍŽá³Ð°ì £¬£¬£¬£¬£¬£¬ £¬£¬ÌìÏÂÖøÃû»¯Ñ§¹«Ë¾°Í˹·ò£¨BASF£©¸±×ܲÃBernd Sachweh½ÌÊÚºÍÖйú¿ÆÑ§ÔºÀî¾²º£ÔºÊ¿µ£µ±±¾½ì¾Û»á¹ú¼ÊѧÊõίԱ»áÖ÷ϯ £¬£¬£¬£¬£¬£¬ £¬£¬Èº¼¯ÁËÀ´×Ô·¨¹ú¡¢µÂ¹úºÍÃÀ¹úµÈÌìϸ÷µØ200¶àÃûµÄר¼ÒѧÕß¡£¡£¡£¡£¡£¡£»£»£»£»£»£»£¾Û»áÄÚÈÝÉæ¼°FormulaºÍFormulationEngineeringµÄ¸÷¸ö·½Ãæ £¬£¬£¬£¬£¬£¬ £¬£¬Ö¼ÔÚΪҩƷ¡¢Ê³Îï¡¢´ß»¯¼ÁºÍ»¯×±Æ·µÈ²î±ðÐÐÒµµÄÖÆ¼ÁÑо¿Ìṩ½»Á÷ʱ»ú £¬£¬£¬£¬£¬£¬ £¬£¬½â¾ö²î±ðÐÐÒµµÄ¹²ÐÔ¿ÆÑ§ÎÊÌâ¡£¡£¡£¡£¡£¡£

PaÆì½¢Ìü¹ÙÍøÒ©ÒµÔÚÕ¾²©Ê¿ºóÑо¿Ö°Ô±Áõ¹ó½ð²©Ê¿Ó¦Ñû¼ÓÈë´Ë´Î¾Û»á £¬£¬£¬£¬£¬£¬ £¬£¬²¢×öÁËÌâΪ¡°ParticleDesign of Itraconazole by Modified Supercritical Antisolvent Method forDissolution Enhancement¡±µÄ±¨¸æ £¬£¬£¬£¬£¬£¬ £¬£¬Ïòº£ÄÚÍâ²Î»á´ú±íչʾÁËPaÆì½¢Ìü¹ÙÍøÒ©Òµ³¬ÁÙ½çÁ÷ÌåÁ£×ÓÉè¼Æ£¨SupercriticalFluid Particle Design £¬£¬£¬£¬£¬£¬ £¬£¬SCF PD£©ÊÖÒÕÁ¢ÒìÆ½Ì¨ÔÚ½â¾ö¶ùÍ¯ÖÆ¼ÁÎÊÌâÉϵÄÏ£ÍûºÍÓÅÊÆ¡£¡£¡£¡£¡£¡£

¹ÌÌåÖÆ¼Á¿ª·¢ÖÐ £¬£¬£¬£¬£¬£¬ £¬£¬Ò©Îï¿ÅÁ£µÄ΢½á¹¹ÊÇÓ°ÏìҩЧµÄÒªº¦ÒòËØ¡£¡£¡£¡£¡£¡£SCF PD×÷ΪÐÂÒ»ÊðÀíÏëµÄÂÌÉ«·ÛÌåÊÖÒÕ £¬£¬£¬£¬£¬£¬ £¬£¬ÔÚÖÆ±¸Ò©Îï΢ÄÉÃ׿ÅÁ£·½Ãæ¾ßÓÐÁ£¾¶Ð¡¡¢ÂþÑÜÕ­¡¢´¿¶È¸ß¡¢ÎÞÈܼÁ²ÐÁô¼°²Ù×÷Ìõ¼þÎÂ˳Ò׿صÈÍ»³öÓŵ㠣¬£¬£¬£¬£¬£¬ £¬£¬¿É¾«×¼µ÷¿ØÒ©Îï¿ÅÁ£µÄ΢½á¹¹ £¬£¬£¬£¬£¬£¬ £¬£¬Ò×ÓÚ¸ÄÉÆÄÑÈÜÒ©ÎïÈܳö¡¢Ìá¸ßҩЧ £¬£¬£¬£¬£¬£¬ £¬£¬ÊµÏÖÒ©ÎïµÄÑÚζ £¬£¬£¬£¬£¬£¬ £¬£¬Éú²ú¸É·ÛÎüÈëÖÆ¼ÁµÈ £¬£¬£¬£¬£¬£¬ £¬£¬ÎªÒ©ÎïµÄ·ÂÖÆºÍÐÂÖÆ¼Á¿ª·¢ÌṩÊÖÒÕ°ü¹Ü¡£¡£¡£¡£¡£¡£½üÄêÀ´ £¬£¬£¬£¬£¬£¬ £¬£¬SCF PDÊÖÒÕÖð½¥³ÉΪAphios¡¢NektarTherapeuticºÍCrystecPharmaµÈ¶à¼ÒÍâÑóÒ½Ò©¹«Ë¾µÄÁ¢ÒìÊÖÒÕ½¹µã £¬£¬£¬£¬£¬£¬ £¬£¬¶à¸öÏà¹Ø²úÆ·ÒѽøÈëÁÙ´²½×¶Î¡£¡£¡£¡£¡£¡£µ«ÓÉÓÚ×°±¸Ç°ÆÚͶ×Ê´ó £¬£¬£¬£¬£¬£¬ £¬£¬Ïà¹ØÊÖÒÕÈ˲Åȱ·¦ £¬£¬£¬£¬£¬£¬ £¬£¬SCF PDÊÖÒÕÔÚº£ÄÚÆóÒµÉÐδ·­¿ªÊ±ÊÆ¡£¡£¡£¡£¡£¡£

×÷Ϊº£ÄÚ×ÅÃû¶ùͯҩÉÏÊÐÆóÒµ £¬£¬£¬£¬£¬£¬ £¬£¬PaÆì½¢Ìü¹ÙÍøÒ©ÒµÖØÊÓ²úÆ·Ñз¢ÓëÁ¢Òì £¬£¬£¬£¬£¬£¬ £¬£¬½¨ÉèÁËÒÔ¶ùͯҩΪÖ÷ÒªÑо¿Æ«ÏòµÄ¹ú¼Ò¼¶ÆóÒµ²©Ê¿ºó¿ÆÑÐÊÂÇéÕ¾ £¬£¬£¬£¬£¬£¬ £¬£¬²¢ÉèÁ¢¡°º£ÄÏÊ¡¶ùÍ¯Ò©ÖÆ¼Á¹¤³ÌÊÖÒÕÑо¿ÖÐÐÄ¡±¡£¡£¡£¡£¡£¡£ÏÖÔÚ £¬£¬£¬£¬£¬£¬ £¬£¬PaÆì½¢Ìü¹ÙÍøÒ©ÒµÒÑÂÊÏȹ¹½¨ÍêÕûµÄSCF PDÊÖÒÕÁ¢ÒìÑо¿Æ½Ì¨£º°üÀ¨SCF PD-Lab×°Öà £¬£¬£¬£¬£¬£¬ £¬£¬¼¤¹âÁ£¶ÈÒÇ¡¢É¨Ãèµç¾µ¡¢XÉäÏß·ÛÄ©ÑÜÉä¡¢ºìÍâ¹âÆ×ºÍ²îʾɨÃèÁ¿ÈÈÒǵÈÏìÓ¦µÄ¿ÅÁ£Î¢½á¹¹±íÕ÷ÊÖ¶Î £¬£¬£¬£¬£¬£¬ £¬£¬²¢ÓÉ×ÊÉîר¼ÒºÍ¾«º·³ÉÔ±×é³É¹¥¹ØÍÅ¶Ó £¬£¬£¬£¬£¬£¬ £¬£¬ÖÂÁ¦ÓÚSCF PDÊÖÒյĹ¤Òµ»¯Éú³¤¡£¡£¡£¡£¡£¡£


Áõ¹ó½ð²©Ê¿ºã¾Ã´ÓÊÂÓëSCF PDÊÖÒÕÏà¹ØµÄÊÂÇé £¬£¬£¬£¬£¬£¬ £¬£¬Æä²©Ê¿ºóÑо¿¿ÎÌâ×ÅÑÛÓÚSCF PDÊÖÒÕÔÚÖÆÒ©ÁìÓòµÄÓ¦Óà £¬£¬£¬£¬£¬£¬ £¬£¬ÈÙ»ñ¡°Öйú²©Ê¿ºó¿ÆÑ§»ù½ðµÚ61ÅúÃæÉÏ×ÊÖú¡±£¨×ÊÖú±àºÅ£º2017M612663£©¡£¡£¡£¡£¡£¡£ÏÖÔÚ £¬£¬£¬£¬£¬£¬ £¬£¬»ùÓÚSCF PDÊÖÒÕÁ¢ÒìÆ½Ì¨ £¬£¬£¬£¬£¬£¬ £¬£¬PaÆì½¢Ìü¹ÙÍøÒ©ÒµÒÑʵÏÖÒÁÇú¿µßò¡¢Í·æßµØÄáºÍÄáÃÀÊæÀûµÈÄÑÈÜÐÔÒ©ÎïµÄÔöÈÜ»òÈܳöµ÷¿Ø £¬£¬£¬£¬£¬£¬ £¬£¬È¡µÃÓÅÒìµÄ½×¶ÎÐÔЧ¹û £¬£¬£¬£¬£¬£¬ £¬£¬ÒÑÉêÇëÏà¹Ø·¢Ã÷רÀû1Ïî £¬£¬£¬£¬£¬£¬ £¬£¬½ÒÏþ¸ßˮƽSCIÂÛÎÄ3ƪ¡£¡£¡£¡£¡£¡£´Ë´Î £¬£¬£¬£¬£¬£¬ £¬£¬Áõ¹ó½ð²©Ê¿ÔÚFormula IX¾Û»áÉÏÏÈÈÝÁËPaÆì½¢Ìü¹ÙÍøÒ©ÒµSCF PDÊÖÒÕÁ¢ÒìÑо¿È¡µÃµÄÏÔ×ÅÏ£Íû £¬£¬£¬£¬£¬£¬ £¬£¬»ñµÃÁËÒµ½çר¼ÒºÍ²Î»á´ú±íµÄ¸ß¶ÈÈÏ¿É £¬£¬£¬£¬£¬£¬ £¬£¬SCF PDÊÖÒÕÒ²ÒýÆðÁËÖî¶à²Î»áÖ°Ô±µÄ¹Ø×¢¡£¡£¡£¡£¡£¡£

δÀ´ £¬£¬£¬£¬£¬£¬ £¬£¬PaÆì½¢Ìü¹ÙÍøÒ©Òµ½«¶¦Á¦´ó¾ÙÍÆ½ø¸ÃÁ¢ÒìÑо¿Æ½Ì¨µÄÉú³¤ £¬£¬£¬£¬£¬£¬ £¬£¬ÖÂÁ¦ÓÚ½â¾ö¼õÁ¿ÔöЧ¡¢Ò©ÎïÑÚζºÍ¸É·ÛÎüÈëÖÆ¼Á¿ª·¢µÈ¶ùÍ¯ÖÆ¼ÁÁ¢ÒìÄÑÌâ £¬£¬£¬£¬£¬£¬ £¬£¬Éú²úÐÔÄÜÓÅÒìµÄ¶ùͯҩÎïÐÂÖÆ¼Á £¬£¬£¬£¬£¬£¬ £¬£¬´òÔìÖйú¶ùͯ´ó¿µ½¡¹¤ÒµµÄÁì¾üÆ·ÅÆ¡£¡£¡£¡£¡£¡£

΢ÐŹ«Öںţºhonzpharma

Copyright ?PaÆì½¢Ìü¹ÙÍø All rights reserved ÇíICP±¸2024039156ºÅ-1
£¨Çí£©ÍøÒ©ÐÅЧÀͱ¸×Ö(2022)µÚ095ºÅ£¨Çí£©-·Çı»®ÐÔ-2022-0022 Powered by vancheer
¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿